Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


07.01.2019

1 Clin Infect Dis
1 Eur J Gastroenterol Hepatol
3 Gastroenterology
1 J Infect Dis
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Infect Dis

  1. PATEL EU, Thio CL, Boon D, Thomas DL, et al
    Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016.
    Clin Infect Dis. 2019 Jan 3. pii: 5272449. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  2. WU ZX, Chen FS, Zhou XL, Huang Q, et al
    Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: an open-label, randomized, controlled study.
    Eur J Gastroenterol Hepatol. 2018 Dec 31. doi: 10.1097/MEG.0000000000001345.
    PubMed     Text format     Abstract available


    Gastroenterology

  3. VERGARA C, Thio CL, Johnson E, Kral AH, et al
    Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35421.
    PubMed     Text format     Abstract available

  4. LIANG TJ, Terrault N
    Viral Hepatitis and Hepatocellular Carcinoma.
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35423.
    PubMed     Text format    

  5. ALTER HJ, Chisari FV
    Is Elimination of Hepatitis B and C a Pipe Dream or Reality?
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35422.
    PubMed     Text format    


    J Infect Dis

  6. RAGHWANI J, Wu CH, Ho CKY, De Jong M, et al
    High resolution evolutionary analysis of within-host hepatitis C virus infection.
    J Infect Dis. 2019 Jan 2. pii: 5269822. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  7. FOSTER GR, Asselah T, Kopecky-Bromberg S, Lei Y, et al
    Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older.
    PLoS One. 2019;14:e0208506.
    PubMed     Text format     Abstract available

  8. MULLHAUPT B, Bruggmann P, Bihl F, Blach S, et al
    Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
    PLoS One. 2018;13:e0209374.
    PubMed     Text format     Abstract available

  9. KAKIZAKI M, Yamamoto Y, Yabuta S, Kurosaki N, et al
    The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes.
    PLoS One. 2018;13:e0205886.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: